WCN26-7939 EFFICACY AND SAFETY OF TACROLIMUS VS CYCLOSPORIN IN PEDIATRIC STEROID-RESISTANT NEPHROTIC SYNDROME: A SYSTEMATIC REVIEW

Read full text Summarise with VIRAT
Authors: Ni Nyoman Berlian Aryadevi, Jessy Hardjo, Henny Adriani Puspitasari
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Cyclosporine A (CyA) and tacrolimus (TAC) are the main calcineurin inhibitors used in treating pediatric steroid-resistant nephrotic syndrome (SRNS). Although CyA was the first widely adopted agent, its efficacy is limited by cosmetic and metabolic adverse effects. Tacrolimus, a newer alternative, offers comparable immunosuppressive efficacy with a potentially improved safety profile. This systematic review aims to compare the efficacy, relapse rates, and adverse-event profiles of CyA and TAC in children with SRNS.

Fields of Study & Subjects

Renal Diseases and Glomerulopathies Renal Transplantation Outcomes and Treatments Chronic Kidney Disease and Diabetes

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105633–105633
Publication date
25 March 2026
Language
EN